M Tanaka

Phase II study of lapatinib, a dual inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase 1 and 2 (Her2/Neu) in patients (pts) with advanced biliary tree cancer (BTC) or hepatocellular cancer (HCC). A California Consortium (CCC-P) Trial

Ramesh K. Ramanathan, Chandra P. Belani, D. A. Singh et al. · Journal of Clinical Oncology · 2006 · 64 citations

Medicine, Oncology, Pharmacology +14

Intraoperative high-dose remifentanil increases post-anaesthetic shivering

Masato Nakasuji, Mai Nakamura, Norie Imanaka et al. · British Journal of Anaesthesia · 2010 · 47 citations · Full text

Medicine, Anesthesiology, Perioperative Medicine +10

Assessment of cytochrome P450 sequences offers a useful tool for determining genetic diversity in higher plant species

Shinşuke Yamanaka, Eizi Suzuki, M Tanaka et al. · Theoretical and Applied Genetics · 2003 · 34 citations

Life Sciences, Genetics, Plant Biology +15

Analysis of plasminogen activation by the plasmin–staphylokinase complex in plasma of α2-antiplasmin-deficient mice

K. Okada, S. Ueshima, M Tanaka et al. · Blood Coagulation & Fibrinolysis · 2000 · 29 citations

Life Sciences, Molecular Biology, Cell Signaling +8